{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:04:27Z","timestamp":1794002667329,"version":"4.8.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with COVID-19 (COVID) may develop acute respiratory distress syndrome with or without sepsis, coagulopathy and visceral damage. While chest CT scans are routinely performed in the initial assessment of patients with severe pulmonary forms, thymus involvement and reactivation have not been investigated so far.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this observational study, we systematically scored the enlargement of the thymus and the lung involvement, using CT scans, in all adult patients admitted to the ICU for COVID or any other cause (control group) at one centre between March and April 2020. Initial biological investigations included nasal detection of SARS-CoV-2 ribonucleic acid by polymerase chain reaction (PCR). In a subgroup of 24 patients with different degrees of pulmonary involvement and thymus hypertrophy, plasma cytokine concentrations were measured and the export of mature T cells from the thymus was estimated simultaneously by PCR quantification of T cell receptor excision circles (TRECs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eighty-seven patients were studied: 50 COVID patients and 37 controls. Non-atrophic or enlarged thymus was more commonly observed in COVID patients than in controls (66% vs. 24%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Thymus enlargement in COVID patients was associated with more extensive lung injury score on CT scans (4 [3\u20135] vs. 2 [1.5\u20134],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01), but a lower mortality rate (8.6% vs. 41.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Other factors associated with mortality were age, lymphopaenia, high CRP and co-morbidities. COVID patients had higher concentrations of IL-7 (6.00 [3.72\u20139.25] vs. 2.17 [1.76\u20134.4] pg\/mL;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04) and higher thymic production of new lymphocytes (sj\/\u03b2TREC ratio\u2009=\u20092.88 [1.98\u20134.51] vs. 0.23 [0.15\u20130.60];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004). Thymic production was also correlated with the CT scan thymic score (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.38,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03) and inversely correlated with the number of lymphocytes (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.56,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In COVID patients, thymus enlargement was frequent and associated with increased T lymphocyte production, which appears to be a beneficial adaptation to virus-induced lymphopaenia. The lack of thymic activity\/reactivation in older SARS-CoV-2 infected patients could contribute to a worse prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-020-03440-1","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T13:02:59Z","timestamp":1609765379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Protective reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome"],"prefix":"10.1186","volume":"25","author":[{"given":"Pelagia","family":"Cuvelier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cou\u00ebdel-Courteille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Dutrieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Naudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Charmeteau de Muylder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Cheynier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1381-6773","authenticated-orcid":false,"given":"Pierre","family":"Squara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Marullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"3440_CR1","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1056\/NEJMe2009758","volume":"382","author":"M Gandhi","year":"2020","unstructured":"Gandhi M, Yokoe DS, Havlir DV. Asymptomatic transmission, the Achilles\u2019 heel of current strategies to control Covid-19. N Engl J Med. 2020;382:2158\u201360.","journal-title":"N Engl J Med"},{"key":"3440_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054\u201362.","journal-title":"Lancet"},{"key":"3440_CR3","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1126\/science.abc3517","volume":"10","author":"H Salje","year":"2020","unstructured":"Salje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, Paireau J, Andronico A, Hoz\u00e9 N, Richet J, Dubost C-L, et al. Estimating the burden of SARS-CoV-2 in France. Science. 2020;10:208\u201311.","journal-title":"Science"},{"key":"3440_CR4","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620\u20139.","journal-title":"J Clin Invest"},{"key":"3440_CR5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. Hlh Across Speciality Collaboration UK: COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033\u20134.","journal-title":"Lancet"},{"key":"3440_CR6","doi-asserted-by":"publisher","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","volume":"214","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, Wang J, Qin Y, Zhang X, Yan X, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clinl Immunol. 2020;214:108393.","journal-title":"Clinl Immunol"},{"key":"3440_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Pere H, Charbit B, Bondet V, Chenevier-Gobeaux C, Breillat P, et al. Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients. Science. 2020;369:718\u201324.","journal-title":"Science"},{"key":"3440_CR8","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","volume":"26","author":"AG Laing","year":"2020","unstructured":"Laing AG, Lorenc A, Barrio DMD, I, Das A, Fish M, Monin L, Munoz-Ruiz M, McKenzie DR, Hayday TS, Francos-Quijorna I, , et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020;26:1623\u201335.","journal-title":"Nat Med"},{"key":"3440_CR9","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","volume":"221","author":"F Wang","year":"2020","unstructured":"Wang F, Nie J, Wang H, Zhao Q, Xiong Y, Deng L, Song S, Ma Z, Mo P, Zhang Y. Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis. 2020;221:1762\u20139.","journal-title":"J Infect Dis"},{"key":"3440_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","volume":"17","author":"M Zheng","year":"2020","unstructured":"Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, Xu Y, Tian Z. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17:533\u20135.","journal-title":"Cell Mol Immunol"},{"key":"3440_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","volume":"39","author":"R Channappanavar","year":"2017","unstructured":"Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39:529\u201339.","journal-title":"Semin Immunopathol"},{"key":"3440_CR12","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/25374","volume":"396","author":"DC Douek","year":"1998","unstructured":"Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 1998;396:690\u20135.","journal-title":"Nature"},{"key":"3440_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1084\/jem.190.4.479","volume":"190","author":"JF Poulin","year":"1999","unstructured":"Poulin JF, Viswanathan MN, Harris JM, Komanduri KV, Wieder E, Ringuette N, Jenkins M, McCune JM, Sekaly RP. Direct evidence for thymic function in adult humans. J Exp Med. 1999;190:479\u201386.","journal-title":"J Exp Med"},{"key":"3440_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1148\/rg.262045213","volume":"26","author":"M Nishino","year":"2006","unstructured":"Nishino M, Ashiku SK, Kocher ON, Thurer RL, Boiselle PM, Hatabu H. The thymus: a comprehensive review. Radiographics. 2006;26:335\u201348.","journal-title":"Radiographics"},{"key":"3440_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/16078454.2020.1833435","volume":"25","author":"SA Mousavi","year":"2020","unstructured":"Mousavi SA, Rad S, Rostami T, Rostami M, Mousavi SA, Mirhoseini SA, Kiumarsi A. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study. Hematology. 2020;25:383\u20138.","journal-title":"Hematology"},{"key":"3440_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.immuni.2004.10.013","volume":"21","author":"ML Dion","year":"2004","unstructured":"Dion ML, Poulin JF, Bordi R, Sylvestre M, Corsini R, Kettaf N, Dalloul A, Boulassel MR, Debr\u00e9 P, Routy JP, et al. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity. 2004;21:757\u201368.","journal-title":"Immunity"},{"key":"3440_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/978-1-59745-395-0_12","volume":"380","author":"ML Dion","year":"2007","unstructured":"Dion ML, Sekaly RP, Cheynier R. Estimating thymic function through quantification of T-cell receptor excision circles. Methods Mol Biol. 2007;380:197\u2013213.","journal-title":"Methods Mol Biol"},{"key":"3440_CR18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/QAD.0000000000000249","volume":"28","author":"J Dutrieux","year":"2014","unstructured":"Dutrieux J, Fabre-Mersseman V, Charmeteau-De Muylder B, Rancez M, Ponte R, Rozlan S, Figueiredo-Morgado S, Bernard A, Beq S, Cou\u00ebdel-Courteille A, et al. Modified interferon-\u03b1 subtypes production and chemokine networks in the thymus during acute simian immunodeficiency virus infection, impact on thymopoiesis. AIDS. 2014;28:1101\u201313.","journal-title":"AIDS"},{"key":"3440_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1148\/radiology.201.2.8888243","volume":"201","author":"S Nicolaou","year":"1996","unstructured":"Nicolaou S, Muller NL, Li DK, Oger JJ. Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy. Radiology. 1996;201:471\u20134.","journal-title":"Radiology"},{"key":"3440_CR20","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1172\/JCI119032","volume":"98","author":"M Murakami","year":"1996","unstructured":"Murakami M, Hosoi Y, Negishi T, Kamiya Y, Miyashita K, Yamada M, Iriuchijima T, Yokoo H, Yoshida I, Tsushima Y, et al. Thymic hyperplasia in patients with Graves\u2019 disease. Identification of thyrotropin receptors in human thymus. J Clin Invest. 1996;98:2228\u201334.","journal-title":"J Clin Invest"},{"key":"3440_CR21","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2214\/ajr.173.5.10541115","volume":"173","author":"M Hara","year":"1999","unstructured":"Hara M, McAdams HP, Vredenburgh JJ, Herndon JE, Patz EF Jr. Thymic hyperplasia after high-dose chemotherapy and autologous stem cell transplantation: incidence and significance in patients with breast cancer. Am J Roentgenol. 1999;173:1341\u20134.","journal-title":"Am J Roentgenol"},{"key":"3440_CR22","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1172\/JCI200522492","volume":"115","author":"FT Hakim","year":"2005","unstructured":"Hakim FT, Memon SA, Cepeda R, Jones EC, Chow CK, Kasten-Sportes C, Odom J, Vance BA, Christensen BL, Mackall CL, et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest. 2005;115:930\u20139.","journal-title":"J Clin Invest"},{"key":"3440_CR23","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1172\/JCI2834","volume":"101","author":"JM McCune","year":"1998","unstructured":"McCune JM, Loftus R, Schmidt DK, Carroll P, Webster D, Swor-Yim LB, Francis IR, Gross BH, Grant RM. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest. 1998;101:2301\u20138.","journal-title":"J Clin Invest"},{"key":"3440_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1086\/315169","volume":"181","author":"KY Smith","year":"2000","unstructured":"Smith KY, Valdez H, Landay A, Spritzler J, Kessler HA, Connick E, Kuritzkes D, Gross B, Francis I, McCune JM, et al. Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. J Infect Dis. 2000;181:141\u20137.","journal-title":"J Infect Dis"},{"key":"3440_CR25","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1038\/s41467-020-17240-2","volume":"11","author":"JW Song","year":"2020","unstructured":"Song JW, Zhang C, Fan X, Meng FP, Xu Z, Xia P, Cao WJ, Yang T, Dai XP, Wang SY, et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun. 2020;11:3410.","journal-title":"Nat Commun"},{"key":"3440_CR26","doi-asserted-by":"publisher","first-page":"eaao2966","DOI":"10.1126\/scitranslmed.aao2966","volume":"10","author":"E Clave","year":"2018","unstructured":"Clave E, Araujo IL, Alanio C, Patin E, Bergstedt J, Urrutia A, Lopez-Lastra S, Li Y, Charbit B, MacPherson CR, et al. Human thymopoiesis is influenced by a common genetic variant within the TCRA-TCRD locus. Sci Transl Med. 2018;10:eaao2966.","journal-title":"Sci Transl Med"},{"key":"3440_CR27","doi-asserted-by":"publisher","first-page":"7818","DOI":"10.4049\/jimmunol.181.11.7818","volume":"181","author":"G Dulude","year":"2008","unstructured":"Dulude G, Cheynier R, Gauchat D, Abdallah A, Kettaf N, Sekaly RP, Gratton S. The magnitude of thymic output is genetically determined through controlled intrathymic precursor T cell proliferation. J Immunol. 2008;181:7818\u201324.","journal-title":"J Immunol"},{"key":"3440_CR28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/cc13775","volume":"18","author":"AA Kalanuria","year":"2014","unstructured":"Kalanuria AA, Ziai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care. 2014;18:208.","journal-title":"Crit Care"},{"key":"3440_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506.","journal-title":"Lancet"},{"key":"3440_CR30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nri2023","volume":"7","author":"R Mazzucchelli","year":"2007","unstructured":"Mazzucchelli R, Durum SK. Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol. 2007;7:144\u201354.","journal-title":"Nat Rev Immunol"},{"key":"3440_CR31","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3389\/fimmu.2017.00588","volume":"8","author":"R Ponte","year":"2017","unstructured":"Ponte R, Rancez M, Figueiredo-Morgado S, Dutrieux J, Fabre-Mersseman V, Charmeteau-de-Muylder B, Guilbert T, Routy JP, Cheynier R, Couedel-Courteille A. Acute simian immunodeficiency virus infection triggers early and transient interleukin-7 production in the gut, leading to enhanced local chemokine expression and intestinal immune cell homing. Front Immunol. 2017;8:588.","journal-title":"Front Immunol"},{"key":"3440_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.smim.2012.02.002","volume":"24","author":"C Hong","year":"2012","unstructured":"Hong C, Luckey MA, Park JH. Intrathymic IL-7: the where, when, and why of IL-7 signaling during T cell development. Semin Immunol. 2012;24:151\u20138.","journal-title":"Semin Immunol"},{"key":"3440_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1126\/science.7686307","volume":"261","author":"K Muegge","year":"1993","unstructured":"Muegge K, Vila MP, Durum SK. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene. Science. 1993;261:93\u20135.","journal-title":"Science"},{"key":"3440_CR34","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","volume":"26","author":"M Liao","year":"2020","unstructured":"Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, Cheng L, Li J, Wang X, Wang F, et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med. 2020;26:842\u20134.","journal-title":"Nat Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03440-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-020-03440-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03440-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T13:09:27Z","timestamp":1609765767000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-020-03440-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3440"],"URL":"https:\/\/doi.org\/10.1186\/s13054-020-03440-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-59411\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-59411\/v1","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"14 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"According to French national regulations for retrospective studies, systematic written informed consent was requested from all patients upon admission, for the potential anonymous use in clinical research studies of clinical and paraclinical data obtained during hospitalisation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests related to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}